Lisa Stafford, MS
Senior Vice President, EVERSANA™ Learning & Performance Solutions
专长:
Lisa brings more than 25 years of experience in the pharmaceutical/biotech/ healthcare industry to EVERSANA. She is an expert in instructional design, leadership and Learning and Performance.
Lisa spent many years working within a hospital setting, in operations, and training, in positions of increasing executive oversite. Most recently, she founded Alkemy Partners, LLC, one of the fastest growing Learning and Development Agencies in the industry. Alkemy Partners was acquired by EVERSANA, and Lisa maintains her role in driving innovation and design for learning solutions globally.
A skillful operational performance leader and executive strategist, Lisa has extensive knowledge in many therapeutic areas, providing launch excellence for many brands, and continuing education through the life cycle of a product. She also has experience in educating medical, commercial and business personnel to increase behavioral modification and performance effectiveness. Additionally, Lisa is proficient in material development in multi-channel options, including digital experiences.
Lisa holds a Bachelor’s degree in Arts in Social Sciences and Creative Arts, and a Master’s Degree in Organizational Leadership.
Articles by Lisa Stafford, MS
Market Access and the Inflation Reduction Act
The Inflation Reduction Act of 2022 (IRA) institutes Medicare changes that include the ability to negotiate drug prices, limit price increases and cap out-of-pocket costs for beneficiaries. Understanding the far-reaching implications of these provisions is crucial for market access professionals to successfully navigate the new dynamics and plan for success in the future. In this […]
The Expanding Oncology Market Prompts Reevaluation of Field Team Training Procedures and Skill Set to Impact Frontline Success
Since 2015, the oncology pipeline has grown by 75%. Simultaneous to the exponential pipeline growth, the market has become increasingly unpredictable with an abundance of challenges such as unprecedented speed to market, securing patient access and affordability and creating compelling stakeholder engagement in a hybrid world. These obstacles call for manufacturers to reevaluate training procedures […]